The immuno-wall devices were then used to perform clinical diagnosis of surgically resected specimens from 22 NSCLC patients previously confirmed as harboring tumors with the E746_A750 deletion, L858R substitution, or EGFR WT according to PCR-based methods and the previously described threshold value (S1 Table). The gene discussed is EGFR; the disease is non-small cell lung carcinoma.